![]() |
![]() |
|
|
||
![]() |
MFIII Human Placenta & Sheep Placenta Packages
SPECIAL PROMOTION PACKAGES
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
Our Celebrities Users
Angelika Kallio, International Model & |
Purpose of injection: Anti-aging, disease prevention.
Initial cycle: 6 vials in 2-3 weeks.
Regular cycle: 1-2 vials per week or even 1 vial every 2 weeks
Of course dosage should be adjusted for individual goals and reactions.
There is no overdosage so you can increase dosage without worrying about any risk.
Excess will pass harmlessly through the body
Note: As with any injection, minor swelling may occur at the injection site on your skin.
Depending on the individual, a complete 50 vial treatment 5-7 days a week, or even 2 vials every other day is recommended.
For sensitive patients you can reduce the number of treatments to 1 or 2 vials each time in daily or alternate days with a maximum of 12 vials each week.
There is no over dosage for our placenta extracts. Excess will pass harmlessly through the body
A repetition of the treatment cycle after 6 and 12 months is possible depending on the illness and the individual patient's health. A deep, subcutaneous or intramuscular injection on the Gluteal area with a thin needle should be given.
MFIII is vigoously tested in independent Swiss laboratories and carries Swiss Certification number SCES002023. MFIII is originally manufactured and packed in Switzerland with full conformity to international stringent standards of the following:
|
ISO9001
|
ISO14001
|
|
GMP (Good Manufacturing Practise)
|
SQS (Swiss Association for Quality & Management System)
|
|
TQM (Total Quality Management)
|
SOP (Standard Operating Procedures)
|
|
European Eurocerta certifications
|
GLP (Good Laboratory Practise)
|
A number of studies have been conducted to ensure the safety of MFIII HP 230. Decades of clinical experience also demonstrate the safety and effectiveness of placenta therapy. Placenta HP is a safe therapeutic agent with the potential to regenerate activity within all human tissue. When introduced into the humans internally, it can reinforce deteriorating cells and lower cellular age. It has been demonstated as an unparalleled anti-aging and health agent
MFIII HP 230 is a very unusual Human placenta product because it uses an ultrafiltration method for sterilization rather than a heat-treatment like most other placenta based products. Other inferior methods use temperatures of 125-180 degrees Celsius to cheaply sterilize human placenta, but this results in damaging or destroying many of the most effective elements.
MFIII holds itself to the highest standards of safety the final product is tested for Hepatitis, HIV and undergoes ELISA testing. Donors are also pre-screened and placenta from eligible donors in the European Union are collected at Government approved hospitals only. Donors suffering from communicable diseases, Hepatitis, HIV, Breech delivery, Twins birth, under weight birth, and Burns are not considered.
In some cases reddening and swelling may occur at the injection site like with any type of injection. A cold compress can be applied and a gentle application of a heparin ointment to cool the area should be sufficient to reduce redness.
Storage
Do not expose to heat or sunlight. Keep out of reach of children. Best kept under refrigeration but not freezing conditions.
Research & Formulated by:
Lab Dom Avmm Biotechnologies Sarl, Switzerland
Manufactured by:
Lab Dom Avmm, Switzerland
Note:
Does not come with syringes.
Orders of less than one box (50 ampoules) will be shipped in alternate packaging.
![]() |
![]() |
|
(50 vials per box) $2200 for one box ($48 per vial)! |
(30 capsules per box) USUALLY $185 for one box!! |
|
Shipping | Effects of MFIII | Manufacturer of MFIII | MFIII-Customer's Voice | Certification of MFIII | About Us | Contact Us | |